Investing Profile

Ash Khanna

InvestorVC
Principal at SV Health Investors
pivotalbiovp.com/team-members...San Francisco Bay Area
Photo of Ash Khanna, Principal at SV Health Investors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
The Wharton School Network
665 CONNECTIONS
The Wharton School Network
665 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Stromedix Inc. Network
267 CONNECTIONS
Bristol Myers Squibb Network
27 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
£200M
CompanyStageDateRound SizeTotal Raised
Evommune
Series BApr 2023$50M
Series ASep 2021$83M
SeedNov 2020$13M
$260M
Co-investors: Rob Hopfner (Pivotal Life Sciences), Mark Chin (Jmi Equity), Derek DiRocco (RA Capital Management)
HotSpot Therapeutics
Series CNov 2021$100M
$210M
Co-investors: Graziano Seghezzi (Sofinnova Partners), Bruce Booth (Atlas Venture), Jill carroll (S.R. One Ltd), Fouad Azzam (EQT Life Sciences)
Bolt Biotherapeutics
Series CJul 2020$94M
Series BFeb 2019$54M
$150M
Co-investors: Peter Moldt (Novo Ventures)
Team Leader Bristol Myers SquibbPresent
Principal SV Health InvestorsPresent
Co-Founder, & Chief Business Officer Stromedix Inc.Present
Partner, Board Member HotSpot Tx, Bolt Bio, Fountain Tx and Evommune Stromedix Inc.Present
University at Buffalo Ph.D. Pharmaceutics
The Wharton School MBA Finance and Healthcare Management
The Wharton School MBA Finance, Healthcare
Sign in with Google →
Sign in with Google →